Keros Therapeutics Inc (KROS) Insider Trading
- $3,000,000.00
- $36,328,034.25
- Aug. 13, 2024
- Julius Knowles
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 13, 2024 | Director | 250,000 | $44.01 | Sell | $11,002,500.00 | |
June 8, 2023 | CFO | 20,000 | $47.79 | Sell | $955,800.00 | |
July 15, 2022 | Insider | 46,034 | $30.00 | Sell | $1,381,020.00 | |
July 13, 2022 | Chief Scientific Officer | 1,916 | $30.00 | Sell | $57,480.00 | |
July 13, 2022 | Insider | 1,916 | $30.00 | Sell | $57,480.00 | |
May 11, 2022 | Insider | 5,300 | $41.90 | Sell | $222,070.00 | |
April 11, 2022 | Insider | 5,300 | $62.77 | Sell | $332,681.00 | |
April 6, 2022 | COO | 1,728 | $65.00 | Sell | $112,320.00 | |
April 4, 2022 | Insider | 7,950 | $60.00 | Sell | $477,000.00 | |
March 11, 2022 | Insider | 2,650 | $53.38 | Sell | $141,457.00 | |
Feb. 11, 2022 | Insider | 2,650 | $52.06 | Sell | $137,959.00 | |
Jan. 11, 2022 | Insider | 2,650 | $53.75 | Sell | $142,437.50 | |
Jan. 5, 2022 | Insider | 2,650 | $60.00 | Sell | $159,000.00 | |
Jan. 5, 2022 | Director | 4,034 | $58.25 | Sell | $234,980.50 | |
Jan. 3, 2022 | Director | 23,555 | $58.01 | Sell | $1,366,425.55 | |
Dec. 15, 2021 | Insider | 735 | $50.00 | Sell | $36,750.00 | |
Dec. 13, 2021 | Insider | 1,915 | $50.55 | Sell | $96,803.25 | |
Nov. 10, 2021 | Insider | 15,900 | $60.00 | Sell | $954,000.00 | |
Nov. 3, 2021 | Director | 15,967 | $41.95 | Sell | $669,815.65 | |
Nov. 1, 2021 | Director | 23,803 | $42.15 | Sell | $1,003,296.45 | |
Oct. 20, 2021 | Director | 4,082 | $38.24 | Sell | $156,095.68 | |
Oct. 18, 2021 | Director | 13,786 | $37.70 | Sell | $519,732.20 | |
Oct. 14, 2021 | Director | 4,383 | $40.13 | Sell | $175,889.79 | |
Oct. 4, 2021 | Director | 3,746 | $40.06 | Sell | $150,064.76 | |
Oct. 1, 2021 | Director | 6,323 | $40.16 | Sell | $253,931.68 | |
Sept. 27, 2021 | Director | 95,302 | $41.17 | Sell | $3,923,583.34 | |
July 1, 2021 | Director | 23,834 | $41.28 | Sell | $983,867.52 | |
June 11, 2021 | Insider | 2,650 | $50.98 | Sell | $135,097.00 | |
June 7, 2021 | Director | 12,796 | $49.89 | Sell | $638,392.44 | |
June 3, 2021 | Director | 7,895 | $47.97 | Sell | $378,723.15 | |
June 1, 2021 | Director | 8,812 | $52.51 | Sell | $462,718.12 | |
May 3, 2021 | Director | 44,816 | $57.48 | Sell | $2,576,023.68 | |
April 12, 2021 | Insider | 1,000 | $59.93 | Sell | $59,930.00 | |
April 5, 2021 | Director | 27,151 | $60.07 | Sell | $1,630,960.57 | |
April 1, 2021 | Director | 11,202 | $58.89 | Sell | $659,685.78 | |
March 3, 2021 | Director | 12,327 | $57.36 | Sell | $707,076.72 | |
March 1, 2021 | Director | 12,979 | $63.09 | Sell | $818,845.11 | |
Feb. 18, 2021 | Director | 28,617 | $60.87 | Sell | $1,741,916.79 | |
Feb. 11, 2021 | Director | 11,561 | $64.82 | Sell | $749,384.02 | |
Feb. 11, 2021 | Insider | 1,000 | $64.84 | Sell | $64,840.00 | |
Nov. 17, 2020 | Director | 60,000 | $50.00 | Buy | $3,000,000.00 |
Insiders are both buying and selling Keros Therapeutics Inc stock.
The insider traders at Keros Therapeutics Inc are: Julius Knowles, Jennifer Lachey, Claudia Ordonez, Lachey Jennifer, Carl L Gordon, Ran Nussbaum, Christopher Rovaldi, and Keith Regnante
The most active insider trader at Keros Therapeutics Inc is Julius Knowles with 21 trades.
Carl L Gordon has sold the most Keros Therapeutics Inc stock with a total value of $22,005,000.00.
Ran Nussbaum has bought the most Keros Therapeutics Inc stock with a total value of $6,000,000.00.
The most recent insider trade for Keros Therapeutics Inc was on Aug. 13, 2024.
The single biggest insider buy for Keros Therapeutics Inc was from Ran Nussbaum with a total value of $3,000,000.00 on Nov. 17, 2020.
The single biggest insider sell for Keros Therapeutics Inc was from Carl L Gordon with a total value of $11,002,500.00 on Aug. 13, 2024.